Concepedia
Statistics
Publications
17
Citations
868
H-Index
15
Active since
1981
Affiliations
Research Triangle Park Foundation(Current)
GlaxoSmithKline (United States)
Shionogi (Japan)
GlaxoSmithKline (United Kingdom)
Duke Medical Center
Paul Savina is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and hiv.
Top concepts
MedicinePharmacologyHivPharmacotherapyImmunologyBiochemistryPharmacokineticsRadiation OncologyVirologyPathology
Publications per year
1981–2014
In Vitro Investigations into the Roles of Drug Transporters and Metabolizing Enzymes in the Disposition and Drug Interactions of Dolutegravir, a HIV Integrase Inhibitor
Melinda J. Reese, Paul Savina, Grant T. Generaux et al. · Drug Metabolism and Disposition · 2012 · 243 citations · Full text
Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans
Stephen Castellino, Lee Moss, David S. Wagner et al. · Antimicrobial Agents and Chemotherapy · 2013 · 136 citations · Full text
Medicine, Human Retrovirus, Mass Balance +12
A sensitive HPLC–MS/MS method for the determination of dolutegravir in human plasma
Chantelle Bennetto‐Hood, Glenn Tabolt, Paul Savina et al. · Journal of Chromatography B · 2013 · 71 citations · Full text
Engineering, Medicine, Bioanalysis +13
5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile
Susan M. Daluge, D. J. M. Purifoy, Paul Savina et al. · Antimicrobial Agents and Chemotherapy · 1994 · 60 citations · Full text
Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment
S Weller, Julie Borland, Shuguang Chen et al. · European Journal of Clinical Pharmacology · 2013 · 59 citations · Full text
Rows per page
1–5 of 17